Charles Schwab
SPRO icon

Charles Schwab’s Spero Therapeutics SPRO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$82.8K Hold
28,565
﹤0.01% 3422
2025
Q1
$20.6K Hold
28,565
﹤0.01% 3461
2024
Q4
$29.4K Hold
28,565
﹤0.01% 3473
2024
Q3
$38.3K Hold
28,565
﹤0.01% 3440
2024
Q2
$37.1K Hold
28,565
﹤0.01% 3546
2024
Q1
$49.1K Hold
28,565
﹤0.01% 3371
2023
Q4
$42K Hold
28,565
﹤0.01% 3417
2023
Q3
$34.6K Hold
28,565
﹤0.01% 3443
2023
Q2
$41.4K Hold
28,565
﹤0.01% 3440
2023
Q1
$41.4K Hold
28,565
﹤0.01% 3380
2022
Q4
$49.4K Buy
+28,565
New +$49.4K ﹤0.01% 3363
2022
Q2
Sell
-65,547
Closed -$571K 3635
2022
Q1
$571K Hold
65,547
﹤0.01% 3061
2021
Q4
$1.05M Buy
65,547
+1,961
+3% +$31.4K ﹤0.01% 2895
2021
Q3
$1.17M Buy
63,586
+3,090
+5% +$56.9K ﹤0.01% 2816
2021
Q2
$845K Buy
60,496
+7,138
+13% +$99.7K ﹤0.01% 2991
2021
Q1
$786K Buy
53,358
+1,527
+3% +$22.5K ﹤0.01% 2929
2020
Q4
$1.01M Buy
51,831
+16,377
+46% +$318K ﹤0.01% 2766
2020
Q3
$396K Hold
35,454
﹤0.01% 2949
2020
Q2
$480K Buy
35,454
+4,090
+13% +$55.4K ﹤0.01% 2846
2020
Q1
$254K Buy
31,364
+4,138
+15% +$33.5K ﹤0.01% 2941
2019
Q4
$262K Hold
27,226
﹤0.01% 3001
2019
Q3
$289K Buy
27,226
+2,108
+8% +$22.4K ﹤0.01% 2972
2019
Q2
$290K Buy
25,118
+5,895
+31% +$68.1K ﹤0.01% 3023
2019
Q1
$247K Buy
19,223
+4,696
+32% +$60.3K ﹤0.01% 2979
2018
Q4
$90K Hold
14,527
﹤0.01% 3097
2018
Q3
$153K Buy
+14,527
New +$153K ﹤0.01% 3099